Aprea Therapeutics Inc (APRE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access APRE Annual Balance Sheets →
Balance sheet data covering Aprea Therapeutics Inc–Jun 30 2025 offers a view into how Jun 30 2026's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent41.23
Cash & Short-term Investments41.00
Prepaid Expense And Other Assets Current0.68
Total Current Assets41.91
Equipment/Property/Plant Net0.06
Other Assets, Noncurrent0.31
Total Assets42.29
Liabilities
Accounts Payable, Current AC0.94
Accrued Liabilities, Current0.40
Other Liabilities, Current1.76
Total Current Liabilities3.09
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.10
Other liabilities, Noncurrent0.63
Accrued Liabilities And Employee Related Liabilities Current2.36
Total Liabilities3.82
Stockholders' Equity
Common Stock Value0.01
Common Stock, Held by Subsidiary etc.-
Additional Paid In Capital Common Stock389.60
Retained Earnings / Accumulated Deficit-340.52
Accumulated Other Comprehensive Income-10.62
Other Equity-10.62
Common Stockholder's Equity38.47
Non-controlling interests & other0.00
Total Stockholder's Equity38.47
Liabilities & Stockholder's Equity42.29
4 historic quarters locked

Sign in to unlock the full Aprea Therapeutics Inc balance sheet history.

About Aprea Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-094544

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.